(This is for FUN!)

Caring for people will never go together in the long term. Every year even better machines and devices than those that already exist and can be used today enter the market. Every year the pharmaceutical industry comes out with new substances and treatments.
Costs are rising. The hospitals’ ground rents are rising. Personnel costs can only be reduced to a certain level, then the entire care structure, which is based on continuity, practical experience and tacit knowledge, collapses.
The digital technology is in itself something good, but as it is updated and upgraded all the time, even more qualified specialist personnel are required. It will require even more training in new techniques and technologies.
The technology will come with metaverse and more 3D technology to offer patients remote, digital, remote operations. A surgeon in India can operate on a patient in Malung. Companies, both private and regional, employ specialists who are employed by completely different companies and companies, within Sweden, the EU or another foreign country. The requirements for effective verbal and written communication will increase. Continuity with practical routines and tacit knowledge ends up in a digital no-man’s land.

Because every time a new machine, device or treatment method comes on the market, there will be patients and relatives who demand that this technology be used for their immediate victims of illness, injury or, often, diffuse pain. These costs will first and foremost affect taxpayers.
Basically, more and more of the technology is about the need for electricity, and that there are insurance companies that are prepared to invest in new and unproven methods.

As long as there are healthcare professionals who can talk to patients and relatives about diffuse pain, and distinguish which pains should be investigated further, perhaps with costly treatments, then even the old-fashioned care structure should work. Unfortunately, people with more difficult, possible, diagnoses are sorted out already at an early stage. The pharmaceutical industry is more focused on producing substances to reduce side effects from other substances, than on finding a more holistic approach.
Psychosocial problems are ignored, as some, which have to do with addiction, are considered ”waste of tax money”.
Specialist healthcare also leads to ”gaps” easily occurring between the various specialties.

Such ”gaps” can arise when even Swedish-born, Swedish-speaking, specialist doctors with different trainings do not understand how to communicate across the boundaries of the specialty. One such question may be about the medicine against high blood fats, cholesterol, where statins, such as sivastatin, are routinely prescribed, even to patients who show no signs of problems with cholesterol whatsoever. How much could such routine drug discharges cost taxpayers each year? The simvastatin itself can lead to side effects, for which other doctors prescribe other substances.